Innovation Network
Understanding the complex biology of disease is the biggest challenge we face in developing new and better medicines and diagnostics.
Unique diversity of approaches
gRED: Genentech Research and Early Development
pRED: Roche Pharma Research and Early Development
Scientific breakthroughs are most likely to occur when scientists are free to tackle problems from different angles and in different ways. Our scientists have this freedom. We believe that a diversity of views, cultures and approaches promotes creativity, especially in research and early development.
To ensure a strong flow of suitable candidate molecules into its development pipeline, Roche has built a unique innovation network of independent research and development centres.
Genentech Research and Early Development (gRED) continues to operate as an independent unit. Similarly, the Pharma Research and Early Development organisation (pRED) enjoys full operational autonomy. In addition to Roche and Genentech, it includes Chugai in Japan and alliances with more than 150 partner organisations worldwide. This promotes a diversity of research approaches, as well as enabling access to new technologies and promising drug candidates.
In 2012 Roche was again recognised as one of our industry’s top partnering organisations. Together with our partners we turn the multiplicity of ideas into medical innovation; about one third of the current projects in Roche’s pipeline have come from these alliances.
Our global systems enable our innovation centers to be thriving and we manage this mainly through visibility and metrics. We have set up common standards, and common understandings of the risks and opportunities in their standards.
Roche has established a class-leading IT system that allows exchange of knowledge around the globe within hours of the experiment being finished. This knowledge leads to prediction and ultimately to better medicines. The distinguishing factor is how we manage this global group and how we allow all partners to access science and innovation in a way that suits them best.
Related Links
We strongly believe that, particularly in Research and Early Development, a diversity of views, cultures and approaches is of utmost importance in fostering creativity.